سعر ريسبيريدون 3 مجم 2025

Risperidone 3 mg film-coated tablets, pack of 30 (3 strips), marketed in Egypt by Pharopharma; atypical antipsychotic.

• Treatment of schizophrenia (adults and adolescents 13-17 years).DailyMed (NLM)
• Acute manic or mixed episodes of Bipolar I disorder, as monotherapy or adjunctive to lithium or valproate.DailyMed (NLM)
• Irritability associated with autistic disorder (pediatric).Population: Children and adolescentsDailyMed (NLM)

• Known hypersensitivity to risperidone, paliperidone or any excipient.International label, same formulation · DailyMed (NLM)

• Boxed warning: elderly patients with dementia-related psychosis treated with antipsychotics have increased risk of death; not approved for dementia-related psychosis.International label, same formulation · DailyMed (NLM)
• Warnings include neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes (hyperglycemia, dyslipidemia, weight gain), hyperprolactinemia, orthostatic hypotension, falls, leukopenia/neutropenia, seizures, dysphagia and priapism.International label, same formulation · DailyMed (NLM)

• Published epidemiologic data have not established a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; a pregnancy exposure registry exists.International label, same formulation · DailyMed (NLM)
• Risperidone and 9-hydroxyrisperidone are present in breast milk (relative infant dose 2.3-4.7%); sedation, failure to thrive, jitteriness and extrapyramidal symptoms reported in breastfed infants.International label, same formulation · DailyMed (NLM)

• Risperidone: Mechanism in schizophrenia unclear; therapeutic activity may be mediated through combined dopamine D2 and serotonin 5-HT2 receptor antagonism; clinical effect results from risperidone plus its active metabolite 9-hydroxyrisperidone (paliperidone).